Læknablaðið - 15.07.2004, Síða 23

FRÆÐIGREINAR / SALÍLYFJAOFNÆMI
22. Quiralte J, Blanco C, Castillo R, Ortega, N, Carillo T.
Anaphylactoid reactions due to nonsteroidal antiinflammatory
drugs: clinical and cross-reactive studies. Ann Allergy Asthma
Immunol 1997; 78: 93-296.
23. Stevenson DD. Adverse reactions to nonsteroidal antiinflam-
matory drugs. N. Am Clin Allergy Immunol 1998; 18: 773-98.
24. Stevenson DD, Zuraw BL. Pathogenesis of Aspirin-
Exacerbated-Respiratory-Disease. Clin Rev All Imm 2003; 24:
169-88.
25. Lee TH, Mechanism of bronchospasm in aspirin-sensitive
asthma (editorial). Am Rev Resp Dis 1993; 148:1442.
26. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg
HL. Release of leukotrienes, prostaglandins, and histaminc
into nasal secretions of aspirin-sensitive asthmatics during
reaction to aspirin. Am Rev Resp Dis 1988; 137: 847-54.
27. Drazen JM. Leukotrienes as mediators of airway obstruction.
Am J Respir Crit Care Med 1998; 158:193-200.
28. Funk, CD. Prostaglandins and Leukotrienes: Advances in
Eicosanoid Biology. Science 2001; 294:1871-5.
29. Dahlen SE, Malmstrom K, Nizankowska E, Dahlen B, Kuna P,
Kowalski M, et al. Improvement of aspirin-intolerant asthma
by montelukast, a leukotriene antagonist: a randomized,
double-blind, placebo-controlled trial. Am J Respir Crit Care
Med 2002; 165: 9-14.
30. Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V.
Antihistamines added to an antileukotriene in treating season-
al allergic rhinitis: histamine and leukotriene antagonism. AI-
lerg Immunol 2004; 36: 67-70,72.
31. Dahlen B, Boreus LO, Anderson P, Andersson R, Zetterstrom
O. Plasma acetylsalicylic acid and salicylic acid levels during
aspirin provocation in aspirin-sensitive subjects. Allergy 1994;
49: 43-9.
32. Arm JP. O’Hickey SP, Hawksworth RJ, Fong CY, Crea AE,
Spur BW, et al. Asthmatic airways have a disproportionate
hyperresponsiveness to LTE4, as compared with normal air-
ways, but not to LTC4, LTD4, methacholine, and histamine.
Am Rev Resp Dis 1990; 142:1112.
33. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH.
Leukotriene-receptor exression on nasal mucosal inflamma-
tory cells in aspirin-sensitive rhinosinitis. N Engl J Med 2002;
347:1493-9.
34. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S,
Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations
increase after aspirin challenge in aspirin-sensitive asthmatic
subjects. Am Rev Resp Dis 1991; 143:1025-9.
35. Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R,
DuBuske L. Differential effects of aspirin and misoprostol
on 15-hydroxyeicosatetraenoic acid generation by leukocytes
from aspirin-sensitive patients. J Allergy Clin Immunol 2003;
112: 505-12.
36. Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M,
Sheller J, et al. Biochemical and clinical evidence that aspir-
in-intolerant asthmatic subjects tolerate the cyclooxygenase
2-selective analgetic drug celecoxib. J Allergy Clin Immunol
2003;111:1116-21.
37. Settipane RA, Stevenson DD. Cross-sensitivity with acet-
aminophen in aspirin sensitive subjects with asthma. J Allergy
Clin Immunol 1989; 84: 26-33.
38. Chandrasekharan NV, Hu Dai, Lamar Turepu Roos K,
Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygen-
ase-1 variant inhibited by acetaminophen and other analgesic/
antipyretic drugs: cloning, structure, and expression. Proc Natl
Acad Sci USA 2002; 99:13926-31.
39. Sánchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F.
Cutaneous reactions to aspirin and nonsteroidal antiinflamma-
tory drugs. Clin Rev Allergy Immunol 2003; 24: 125-36.
40. Grattan CEH. Aspirin Sensitivity and Urticaria. Clin Exp
Dermatol 2003; 28:123-7.
41. Greaves MW. Chronic Urticaria. N Engl J Med 1995; 332:1767-
72.
42. Mathison DA, Lumry WR, Stevenson DD. Aspirin in chronic
urticaria and/or angioedema: Studies of sensitivity and desen-
sitization. J Allergy Clin Immunol 1982; 69:135.
43. Bjömsdóttir US, Sigurðardóttir SÞ, Lúðvíksson BR. Ofnæm-
islost - meingerð, algengi og meðferð. Læknablaðið 2002; 88:
551-9.
44. Gíslason D. Lífshættuleg ofnæmisviðbrögð. Læknablaðið 2002;
88: 547-8.
45. van der Klauw MM, Wilson JH, Stricker BH. Drug-associated
anaphylaxis: 20 years of reporting in The Netherlands (1974-
1994) and review of the literature. Clin Exp Allergy 1996; 26:
1355-63.
46. Settipane RA, Constantine HP, Settipane GA. Aspirin intol-
erance and recurrent urticaria in normal adults and children.
Epidemiol Rev Allergy 1980; 35:149-54.
47. Stevenson DD. Diagnosis, prevention, and (sic) treatment of
adverse reactions to aspirin and nonsteroidal anti-inflamma-
tory dmgs. J Allergy Clin Immunol 1984; 74: 617-22.
48. Sanchez-Hernandez MC, Delgado J, Navarro AM, Orta JC,
Hernandez M, Conde J. Seizures induced by NSAID. AUergy
1999; 54: 90-1.
49. Greenberg GN. Recurrent sulindac-induced aseptic meningitis
in a patient tolerant to the other NSAIDs. South Med J 1988;
81: 1463-4.
50. Erdmann SM, Heussen N, Moll-Slodowy S, Merk HF, Sachs
B. CD63 expression on basophils as a tool for the diagnosis of
pollen-associated food allergy: sensitivity and specificity. Clin
Exp Allergy 2003; 33: 607-14.
51. Bochenek G, Niz Ankowska E, Szczeklik A. Testing for aspirin
hypersensitivity. Allergy 2002; 57: 562-5.
Læknablaðið 2004/90 551